CD43-independent augmentation of mouse T-cell function by glycoprotein cleaving enzymes

Immunology

Volumn 119, Issue 2, 2006, Pages 178-186

  Berger, Scott B ^a   Sadighi Akha, Amir A ^a   Miller, Richard A ^a,b   Garcia, Gonzalo G ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c 3017 BSRB ^*  (United States)

Author keywords

Ageing; Cellular activation; Glycosylation; Immunosenescence; Signal transduction

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; BACTERIAL ENZYME; GLYCAN; GLYCOPROTEIN; GLYCOSIDASE; GLYCOSYLATED PROTEIN; LEUKOSIALIN; O SIALOGLYCOPROTEIN ENDOPEPTIDASE; PROTEINASE; SIALIC ACID; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL CELL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

AGING; ANIMALS; ANTIGENS, CD; ANTIGENS, CD43; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CALCIUM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; GLYCOSYLATION; LECTINS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; MICE; MICE, KNOCKOUT; NEURAMINIDASE; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION;

EID: 33748752299     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02419.x     Document Type: Article

References (42)

1. Pawelec G, Solana R, Remarque E, Mariani E. Impact of aging on innate immunity. J Leukoc Biol 1988; 64:703-12.
2. Plackett TP, Boehmer ED. Faunce DE, Kovacs EJ. Aging and innate immune cells. J Leukoc Biol 2004; 76:291-9.
3. Miller RA, Berger SB, Burke DT, Galecki A, Garcia GG, Harper JM, Sadighi Akha AA. T cells in aging mice: genetic, developmental, and biochemical analyses. Immunol Rev 2005; 205:94-103.
4. Riley RL, Blomberg BB, Frasca D. B cells, E2A, and aging. Immunol Rev 2005; 205:30-47.
5. Szakal AK, Aydar Y, Balogh P, Tew JG. Molecular interactions of FDCs with B cells in aging. Semin Immunol 2002; 14:267-74.
6. Grubeck-Loebenstein B, Wick G. The aging of the immune system. Adv Immunol 2002; 80:243-84.
7. Nikolich-Zugich J. T cell aging: naive but not young. J Exp Med 2005; 201:837-40.
8. Aspinall R. Age-related changes in the function of T cells. Microsc Res Techn 2003; 62:508-13.
9. Taub DD, Longo DL. Insights into thymic aging and regeneration. Immunol Rev 2005; 205:72-93.
10. Stoltzner G, Makinodan T. Age dependent decline in proliferation of lymphocytes. Adv Exp Med Biol 1975; 61:21-37.
11. + T cells. Immunol Rev 2005; 205:220-8.
12. + T cells. J Immunol 2002; 169:5021-7.
13. + T cell activation reversed by glycoprotein endopeptidase. Eur J Immunol 2003; 33:3464-72.
14. Cullinan P, Sperling AI, Burkhardt JK. The distal pole complex: a novel membrane domain distal to the immunological synapse. Immunol Rev 2002; 189:111-22.
15. Ardman B, Sikorski MA. Staunton DE. CD43 interferes with T-lymphocyte adhesion. Proc Natl Acad Sci USA 1992; 89:5001-5.
16. Manjunath N, Correa M, Ardman M, Ardman B. Negative regulation of T-cell adhesion and activation by CD43. Nature 1995; 377:535-8.
17. Manjunath N, Johnson RS, Staunton DE, Ardman, B. Targeted disruption of CD43 gene enhances T lymphocyte adhesion. J Immunol 1993; 151:1528-34.
18. + T cells of old and young mice. Int Immunol 2005; 17:983-91.
19. Garcia GG, Berger SB, Sadighi Akha AA, Miller RA. Age-associated changes in glycosylation of CD43 and CD45 on mouse CD4 T cells. Eur J Immunol 2005; 35:622-31.
20. Tamir A, Eisenbraun MD, Garcia GG, Miller RA. Age-dependent alterations in the assembly of signal transduction complexes at the site of T cell/APC interaction. J Immunol 2000; 165:1243-51.
21. Sperling AI, Sedy JR, Manjunath N, Kupfer A, Ardman B, Burkhardt JK. Cutting edge. TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site. J Immunol 1988; 161:6459-62.
22. Stockton BM, Manjunath N, Ardman B, von Andrian UH. Negative regulation of T cell homing by CD43. Immunity 1988; 8:373-81.
23. Woodman RC, Johnston B, Hickey MJ, Teoh D, Reinhardt P, Poon BY, Kubes P. The Functional paradox of CD43 in leukocyte recruitment: a study using CD43-deficient mice. J Exp Med 1998; 188:2181-6.
24. Thurman EC, Walker J, Jayaraman S, Manjunath N, Ardman B, Green JM. Regulation of in vitro and in vivo T cell activation by CD43. Int Immunol 1998; 10:691-701.
25. Ostberg JR, Barth RK, Frelinger JG. The Roman god Janus. A paradigm for the function of CD43. Immunol Today 1998; 19:546-50.
26. Tong J, Allenspach EJ, Takahashi SM, Mody PD, Park C, Burkhardt JK, Sperling AI. CD43 regulation of T cell activation is not through steric inhibition of T cell-APC interactions but through an intracellular mechanism. J Exp Med 2004; 199:1277-83.
27. Sperling AI, Green JM, Mosley RL, Smith PL, DiPaolo RJ, Klein JR, Bluestone JA, Thompson CB. CD43 is a murine T cell costimulatory receptor that functions independently of CD28. J Exp Med 1995; 182:139-46.
28. Onami TM, Harrington LE, Williams MA et al. Dynamic regulation of T cell immunity by CD43. J Immunol 2002; 168:6022-31.
29. + memory T cells: analysis using a monoclonal antibody to CD43 that has a novel lineage specificity. J Immunol 2004; 172:7246-53.
30. Carlow DA, Corbel SY, Ziltener HJ. Absence of CD43 fails to alter T cell development and responsiveness. J Immunol 2001; 166:256-61.
31. Iwashima M. Kinetic perspectives of T cell antigen receptor signaling. A two-tier model for T cell full activation. Immunol Rev 2003; 191:196-210.
32. Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 1994; 12:85-116.
33. D'Oro U, Ashwell JD. Cutting edge. The CD45 tyrosine phosphatase is an inhibitor of lck activity in thymocytes. J Immunol 1999; 162:1879-83.
34. Irie-Sasaki J, Sasaki T, Matsumoto W et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 2001; 409:349-54.
35. Dornan S, Sebestyen Z, Gamble J et al. Differential Association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction. J Biol Chem 2002; 277:1912-8.
36. McKenney DW, Onodera H, Gorman L, Mimura T, Rothstein DM. Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving Vav in T cells. J Biol Chem 1995; 270:24949-54.
37. Moody AM, North SJ, Reinhold B et al. Sialic acid capping of CD8beta core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction. J Biol Chem 2003; 278:7240-6.
38. + T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity 2000; 12:273-83.
39. + T cell responses. J Immunol 2004; 173:275-84.
40. Moody AM, Chui D, Reche PA, Priatel JJ, Marth JD, Reinherz EL. Developmentally regulated glycosylation of the CD8αβ coreceptor stalk modulates ligand binding. Cell 2001; 107:501-12.
41. Demetriou M, Granovsky M, Quaggin S, Dennis JW. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001; 409:733-9.
42. Ma BY, Mikolajczak SA, Yoshida T, Yoshida R, Kelvin DJ, Ochi A. CD28 T cell costimulatory receptor function is negatively regulated by N-linked carbohydrates. Biochem Biophys Res Commun 2004; 317:60-7.